100% agree. The market hasn’t got a clue what the now desrisked IMU is worth.
Yesterdays run doesn’t factor the announcement in at all.
Current Market Cap is $970m. But what is HerVAX now worth. The BCell platform has now been fully validated. HerVAX has just blown Herceptin away. In every aspect HerVAX is outstanding compared to herceptin. Herceptin did have sales of over US$8bn at its peak. Herceptin now competes with Biosimilars (generics) for market share.
The poster Unbelievable did a good post here several years ago saying the drugs sell for 5 times the peak sales they achieve. Which would have valued Herceptin at $40bn a few years back.
Even without Ph3 being done, it’s hard to see HerVAX being worth less than US$5bn today. Gastric cancer does not have any effective safe treatments. It’s a huge disease.
So that’s $7.2bn in AUD . That’s $1.78 per share. So even if you cut that down to half it’s still .89 cents. The following link gives us a good idea on the money big Pharma earn and pay for these drugs.
Don’t let anybody mislead you on the value of IMU shares. If you read that article and links , you will begin ti understand the enormity of IMU’s potential. When the hammer drops IMU will take off.
That’s not even thinking about “Oncarlytics” which we now know is producing “beautiful data”. We all know exactly what LC means when she uses that phrase.
I was buying up yesterday to increase my chips with this now derisked biotech.
IMU Price at posting:
24.0¢ Sentiment: Buy Disclosure: Held
